$CYTR,,, apparently the ASCO presentation was yest
Post# of 22995
Phase 3 Study of Aldoxorubicin vs Investigator’s Choice as Treatment for Relapsed/Refractory Soft Tissue Sarcomas
Sant Chawla, M.D.
Principal Investigator
Director, Sarcoma Oncology Center Santa Monica, California


https://twitter.com/twitter/statuses/957208055766241280